For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Maintenance therapy with subcutaneous infliximab was more effective than placebo regardless of disease location or segment among patients with Crohn’s disease, according to data published in Clinical ...

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...

Unlike conventional procedures that require large incisions, minimally invasive surgeries are performed through tiny openings ...

PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...

The EU project ENDOTARGET aims to improve the quality of life of people with rheumatic diseases. As part of a population cohort analysis, preliminary analyses provided initial insights into the ...

With smart DMPK strategies, cross-domain collaboration, and strong CDMO support, companies are pushing past the challenges of ...

A neurologist explains how common medications can cause vitamin B12 deficiency, damage nerves over time, and trigger numbness ...

Market OverviewThe global ostomy devices market is projected to grow at a healthy rate of 4–5% and is expected to reach approximately USD 3.2 billion by 2026. This steady expansion is driven by rising ...

PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn's disease (FSCD) to address signifi ...

A county surgeon has carried out a new operation which marks the launch of a new pouch service for some suitable complex ...